Rongyao 2017: Sina Medicine Annual Awards Open for Nominations
On November 8, the “Rongyao 2017·Sina Medicine Annual Awards” selection process, hosted by Sina Medicine and co-organized with the support of over ten authoritative media outlets and data agencies—including VCBeat, New Health World, Health界 (Health Circle), YaoDu (Pharma渡), Firestone Creation, Saibailan, Pharmacy Manager, E-Drug Manager, Bio360, Siqi Circle, and Pharma Brief—officially kicked off.
The event features four award categories and ten lists, covering major sectors of the 2017 pharmaceutical industry, including manufacturing, commerce, retail, smart healthcare, e-commerce, medical devices, and investment and financing. It aims to document and witness the trajectory of era-defining changes while identifying and highlighting exemplary role models.
This initiative will adhere to the principle of maximizing impact and value, continuously integrating industry media and authoritative institutions for certification, and striving to enhance the synergistic effects and brand influence of the rankings.
Registration for the event is now in full swing. Eligible enterprises and individuals are welcome to apply enthusiastically.
2017 Outstanding Contributors to China's Pharmaceutical Industry
Evaluation Criteria:
1. The enterprise where the nominee is employed must be a formally registered entity within China;
2. The nominees shall possess a certain degree of influence and public recognition within China’s pharmaceutical industry and related fields;
3. The nominees have demonstrated outstanding performance and made exceptional contributions to China's pharmaceutical industry and related fields;
4. The nominees demonstrate unique philosophies in corporate management and team building, with their achievements serving as industry benchmarks.
Top 10 Business Leaders in China’s Pharmaceutical Industry in 2017
Evaluation Criteria:
1. The enterprise where the candidate is employed must be a formally registered entity within China;
2. The nominees shall possess a certain degree of influence and public recognition within China’s pharmaceutical industry and related fields;
3. Nominees have demonstrated outstanding performance and made exceptional contributions to China’s pharmaceutical industry and related fields;
4. The nominees demonstrate unique philosophies in corporate management and team building, with their achievements serving as industry benchmarks.
Top 10 Outstanding Startups in China’s Pharmaceutical Industry in 2017
Evaluation Criteria:
1. Participating enterprises must be formally registered within China and have been established for no more than five years;
2. Registration is open to all relevant sectors of China’s pharmaceutical industry, including pharmaceutical manufacturing, pharmaceutical distribution, Internet+ healthcare, pharmaceutical investment, and medical insurance;
3. The company’s products have achieved a certain market share and competitiveness, garnering widespread attention within the industry.
4. The company has established a strong brand image during its development, with excellent brand awareness and reputation.
Top 10 Most Influential Companies in China's Pharmaceutical Industry in 2017
Evaluation Criteria:
1. Participating enterprises must be officially registered within China;
2. The company holds significant influence in China’s pharmaceutical industry and has played a prominent role in advancing the development of the sector;
3. The company holds a high market share, demonstrates outstanding performance, and possesses core competitive advantages;
4. The company has built a strong brand image through high-quality products and services during its development, achieving excellent brand awareness and reputation.
Top 10 Most Popular Gold-Standard Pharmacies of 2017
Evaluation Criteria:
1. Participating enterprises must be officially registered within the territory of China;
2. The company is highly influential in China’s pharmaceutical distribution sector and has played a prominent role in advancing the development of China’s pharmaceutical retail industry.
3. The company holds a high market share, demonstrates outstanding performance, and possesses core competitive advantages;
4. Throughout its development, the company has established a strong brand image through superior quality and service, achieving high brand awareness and an excellent reputation.
2017 Outstanding Public Welfare Projects by Pharmaceutical Enterprises
Evaluation Criteria:
1. The participating enterprises shall be formally registered entities within the territory of China;
2. The company enjoys excellent brand awareness and reputation in China’s pharmaceutical industry, with a certain market share;
3. The project under evaluation is a public relations practice activity in which an enterprise contributes personnel, materials, or financial resources to sponsor and support health-related public welfare initiatives.
4. The project under evaluation demonstrates significant practical utility and exerts a certain degree of social influence.
2017 Most Socially Responsible Listed Pharmaceutical Company
Evaluation Criteria:
1. Participating enterprises must be officially registered listed companies within China;
2. The company enjoys an excellent reputation and high brand recognition in China’s pharmaceutical industry, with a certain market share;
3. While generating profits and fulfilling responsibilities to shareholders, the company effectively balances employee rights and occupational health, maintaining a strong reputation.
4. The enterprise prioritizes production safety and resource conservation during the manufacturing process, thereby serving as a positive social model and contributing to environmental protection.
Selection Criteria for the Seven Major Awards
The final ranking is determined by a composite score comprising two components: online voting (60% weight) and review by the Organizing Committee (40% weight). The online voting component aggregates results from the dedicated voting portal, WeChat voting, and Weibo voting. The Organizing Committee conducts the selection in accordance with the principles of “authority, impartiality, fairness, and transparency.” All enterprises and individuals meeting the eligibility criteria are welcome to apply.
2017 Sina Medicine Annual Outstanding Author
Nomination Method: Nominations are based on the top 20 individual columnists ranked by Sina Medicine’s official comprehensive statistics, including metrics such as submission volume and readership.
2017 Sina Medicine's Most Watched Media Column
Nomination Method: The top 10 columnists are nominated based on the official comprehensive statistics of Sina Medicine, considering factors such as the number of submissions and page views for their media columns.
2017 Sina Medicine Most Influential Enterprise Column
Nomination Method: Nominations are based on the top 10 corporate columns ranked by Sina Medicine’s official comprehensive statistics, considering factors such as the number of submissions and page views by columnists.
Sina Medicine Column Award Selection Rules
Submissions and views collectively account for 50%, online public voting accounts for 30%, and the organizing committee’s evaluation accounts for 20%.
Registration Instructions:
Except for the Sina Medicine Column Award, all other awards are open to enterprises or individuals who meet the eligibility criteria.
Registration Method:
① Follow the official WeChat account of Sina Medicine and click on the menu item “Rongyao 2017” to register;
② Direct email registration: Compose an email and send it to editor@med.sina.com, with the subject line stating “2017 Selection + Award Name + Registration”.
Click here for the registration link
Organizer:
Sina Medicine
Media Support:
VCBeat, New Health World, Health界, Bio360, Sai Bailan, Pharmacy Manager, Siqi Circle, E-Drug Manager, Drug Briefing……
Data Support:
PharmaDJ, Firestone Creation...